Biologics

Showing 1 of 2 from 2 results
Biologics - Total results - 2
Biocon Q4 net profit falls 42% to Rs 123 cr due to one-time COVID-19 impact; total income up 6%
Business

Biocon Q4 net profit falls 42% to Rs 123 cr due to one-time COVID-19 impact; total income up 6%

Biotechnology major Biocon has reported a 42 percent decline in its consolidated net profit to Rs 123 crore for the quarter ended March 2020, mainly on account of the one-time coronavirus-related impact on its biologics business

Biotech drugs maker Samsung BioLogics IPO expected to raise $2 billion in South Korea
News & Analysis

Biotech drugs maker Samsung BioLogics IPO expected to raise $2 billion in South Korea

Samsung BioLogics Co Ltd, a contract manufacturer of biotech drugs for global pharmaceutical firms, said on Tuesday its initial public offering is expected to raise as much as $2 billion in what is set to be South Korea's third-largest IPO.